Hims & Hers Health, Inc. CEO Andrew Dudum Sold 175,661 Shares.
Filings Track
05-20
CEO of Hims & Hers Health, Inc. (Ticker: HIMS), Andrew Dudum, sold a total of 175,661 Class A common shares on May 16, 2025, across several transactions under his 10b5-1 trading plan, with prices ranging from $57.43 to $59.525. Additionally, Dudum exercised stock options acquiring 125,335 Class A common shares. Such sales by a CEO may exert pressure on the stock price, and investors should remain vigilant of market trends.